cbdMD Reports Fiscal 2025 Net Sales of Up to $19.3 Million and Reduced Net Loss
cbdMD Inc. reported preliminary unaudited financial results for fiscal 2025, with net sales expected between $19.1 million and $19.3 million, slightly down from $19.5 million in 2024. The fourth quarter sales are projected to rise 3% to 5% year-over-year. The company anticipates reducing its net loss to $1.9 million-$2.1 million, improving from a $3.7 million loss in 2024. cbdMD highlighted positive revenue growth and business model improvements.
cbdMD Inc. reported preliminary unaudited financial results for the fourth quarter and full fiscal year ended September 30, 2025. Net sales revenue for fiscal 2025 is expected to range between $19.1 million and $19.3 million, compared to $19.5 million in fiscal 2024. For the fourth quarter of fiscal 2025, net sales revenue is expected to be between $4.7 million and $4.9 million, up from $4.6 million in the same period last year, representing an increase of 3% to 5%. The company expects its net loss for fiscal 2025 to improve to a range of $1.9 million to $2.1 million, compared to a net loss of $3.7 million in fiscal 2024. cbdMD highlighted actions taken to strengthen its business and operating model and reported positive sequential and year-over-year revenue growth for the fourth quarter. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. cbdMD Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: CL30521) on November 21, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT)
